--- title: "Lifevantage Q2 Earnings Summary & Key Takeaways" type: "News" locale: "zh-CN" url: "https://longbridge.com/zh-CN/news/274866746.md" description: "Lifevantage (NASDAQ:LFVN) reported its Q2 earnings on February 4, 2026, missing estimates by 16.67% with an EPS of $0.15 against an expected $0.18. Revenue decreased by $18.83 million compared to the previous year. In the last quarter, the company also missed EPS estimates, but shares rose by 4.43% the following day. Past performance shows fluctuations in EPS and revenue across recent quarters. For more earnings updates, visit Lifevantage's earnings calendar." datetime: "2026-02-04T21:08:15.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/274866746.md) - [en](https://longbridge.com/en/news/274866746.md) - [zh-HK](https://longbridge.com/zh-HK/news/274866746.md) --- > 支持的语言: [English](https://longbridge.com/en/news/274866746.md) | [繁體中文](https://longbridge.com/zh-HK/news/274866746.md) # Lifevantage Q2 Earnings Summary & Key Takeaways **Lifevantage** (NASDAQ:LFVN) announced its Q2 earnings on Wednesday, February 4, 2026 at 04:05 PM. Here's a breakdown of the earnings report. ### Earnings Lifevantage missed estimated earnings by -16.67%, reporting an EPS of $0.15 versus an estimate of $0.18. Revenue was down $18.83 million from the same period last year. ### Overview of Past Earnings Last quarter the company missed on EPS by $0.0 which was followed by a 4.43% increase in the share price the next day. Here's a look at Lifevantage's past performance: **Quarter** **Q1 2026** **Q4 2025** **Q3 2025** **Q2 2025** **EPS Estimate** 0.18 0.18 0.14 0.13 **EPS Actual** 0.18 0.17 0.26 0.22 **Revenue Estimate** 54.20M 58.36M 60.96M 67.41M **Revenue Actual** 47.56M 55.11M 58.40M 67.76M To track all earnings releases for Lifevantage visit their earnings calendar here. This article was generated by Benzinga's automated content engine and reviewed by an editor. ### 相关股票 - [Lifevantage (LFVN.US)](https://longbridge.com/zh-CN/quote/LFVN.US.md) ## 相关资讯与研究 - [LifeVantage meldet Umsatz im zweiten Quartal 2026 von 48,93 Mio. USD, Rückgang um 27,8 Prozent](https://longbridge.com/zh-CN/news/274865595.md) - [LifeVantage Q2 revenue falls 27.8%, misses estimates](https://longbridge.com/zh-CN/news/274867530.md) - [Old Mutual Non-GAAP EPS of R 1.89](https://longbridge.com/zh-CN/news/279391689.md) - [Expion360 GAAP EPS of -$1.13, revenue of $9.65M](https://longbridge.com/zh-CN/news/279483561.md) - [Bicycle Therapeutics GAAP EPS of -$0.29 beats by $0.66, revenue of $47.96M beats by $40.88M](https://longbridge.com/zh-CN/news/279421873.md)